Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles

髓性白血病 医学 免疫学 髓样 癌症研究
作者
Aditi Singh,Nikolai Norevik Myklebust,Sarah Marie Vie Furevik,Ragnhild Haugse,Lars Herfindal
出处
期刊:Current Medicinal Chemistry [Bentham Science Publishers]
卷期号:26 (28): 5278-5292 被引量:9
标识
DOI:10.2174/0929867326666190517114450
摘要

Acute Myeloid Leukaemia (AML) is the neoplastic transformation of Hematopoietic Stem Cells (HSC) and relapsed disease is a major challenge in the treatment. Despite technological advances in the field of medicine and our heightened knowledge regarding the pathogenesis of AML, the initial therapy of "7+3" Cytarabine and Daunorubicin has remained mainly unchanged since 1973. AML is a disease of the elderly, and increased morbidity in this patient group does not allow the full use of the treatment and drug-resistant relapse is common. Nanocarriers are drug-delivery systems that can be used to transport drugs to the bone marrow and target Leukemic Stem Cells (LSC), conferring less side-effects compared to the free-drug alternative. Nanocarriers also can be used to favour the transport of drugs that otherwise would not have been used clinically due to toxicity and poor efficacy. Liposomes are a type of nanocarrier that can be used as a dedicated drug delivery system, which can also have active ligands on the surface in order to interact with antigens on the target cells or tissues. In addition to using small molecules, it is possible to attach antibodies to the liposome surface, generating so-called immunoliposomes. By using immunoliposomes as a drug-delivery system, it is possible to minimize the toxic side effects caused by the chemotherapeutic drug on healthy organs, and at the same time direct the drugs towards the remaining AML blasts and stem cells. This article aims to explore the possibilities of using immunoliposomes as a drug carrier in AML therapy. Emphasis will be on possible target molecules on the AML cells, leukaemic stem cells, as well as bone marrow constituents relevant to AML therapy. Further, some conditions and precautions that must be met for immunoliposomes to be used in AML therapy will be discussed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
GL发布了新的文献求助10
3秒前
乐乐应助如意枫叶采纳,获得10
3秒前
4秒前
史念薇发布了新的文献求助10
4秒前
xixi完成签到 ,获得积分10
4秒前
6秒前
青野发布了新的文献求助10
8秒前
11秒前
12秒前
高贵梦露完成签到,获得积分10
12秒前
14秒前
16秒前
量子星尘发布了新的文献求助10
17秒前
如意枫叶发布了新的文献求助10
18秒前
18秒前
19秒前
19秒前
21秒前
22秒前
23秒前
赘婿应助GL采纳,获得10
23秒前
24秒前
24秒前
Archer宇完成签到,获得积分10
24秒前
狸花小喵发布了新的文献求助10
26秒前
科研废物完成签到 ,获得积分10
26秒前
27秒前
28秒前
29秒前
30秒前
32秒前
33秒前
潇湘雪月发布了新的文献求助10
34秒前
34秒前
35秒前
ding应助咩咩羊采纳,获得10
35秒前
36秒前
quququ发布了新的文献求助30
37秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136